Louisiana House Bill HCR162

Louisiana 2015 Regular Session

• Introduced: 5/19/15
• Refer: 5/19/15
• Report Pass: 5/20/15
• Engrossed: 6/1/15
• Report Pass: 6/2/15
• Passed: 6/7/15

Caption

Requests the Commission on Perinatal Care and Prevention of Infant Mortality to study and make recommendations concerning prevention and treatment of neonatal abstinence syndrome

Impact

The potential impact of HCR162 on state laws revolves around improving public health policies related to maternal and infant care. By urging a focused analysis on NAS, the resolution signifies a commitment from the state legislature to confront an increasing crisis in neonatal health linked to substance abuse. Addressing NAS through legislative guidance can lead to the implementation of state-wide initiatives aimed at reducing infant mortalities and improving health outcomes for newborns exposed to opioids during pregnancy.

Summary

House Concurrent Resolution 162 (HCR162) serves as a legislative mandate for the Commission on Perinatal Care and Prevention of Infant Mortality to investigate and develop recommendations related to neonatal abstinence syndrome (NAS). With growing concerns over the rising prevalence of NAS linked to maternal opioid use, HCR162 aims to address a critical public health issue by requesting a comprehensive study that will inform better strategies for prevention, screening, and treatment of affected infants. A report detailing findings and recommendations is to be submitted to the legislative committees on health and welfare by March 1, 2016.

Sentiment

The sentiment surrounding HCR162 appears to be supportive, particularly among public health advocates who recognize the urgent need for enhanced strategies related to NAS. The resolution reflects a proactive approach by legislators to engage experts and seek data-driven recommendations. However, it also underscores the existing challenges in accurately documenting and managing NAS in Louisiana, suggesting a need for more robust healthcare frameworks to tackle this issue effectively.

Contention

A notable point of contention surrounding HCR162 is the underlying implications of addressing NAS amid the heightened national discourse on opioid dependence. While there is consensus on the necessity of the study, stakeholders may diverge on the methods and extent of interventions recommended. Potential debates could arise regarding funding, resource allocation for the program, and the involvement of various sectors of healthcare in the solution. The resolution opens up avenues for dialogue on balancing public health initiatives with the complexities of addiction.